Broadcast Date: July 11th, 2017
Time: 11:00 am ET, 8:00 am PT
The size of poly(lactic-co-glycolic) acid (PLGA) microparticles is of critical importance for polymer degradation and drug release rates. Current methods for the characterization of PLGA microparticle size provide only limited or no quantitative information or may overestimate size due to the presence of agglomerated particles. In this GEN webinar, we will learn current methodology for using Micro-Flow Imaging (MFI) to assess size and agglomeration of PLGA microparticles—since MFI is able to differentiate between fines, monospheres, and agglomerates based on particle morphology and quantify the number and volume fraction of each particle population. Additionally, we will find out how this information can be applied to the formulation and process development of PLGA microparticles and to monitor the physical stability of these particles after reconstitution.
Who Should Attend
- Investigators interested in Micro-Flow Imaging
- Bioprocessing scientists
- Researchers involved in particle analysis
- Scientists developing protein therapeutics
- QC/QA scientists
- Scientists interested in encapsulation
You Will Learn
- The benefits of MFI in biopharmaceutical process analysis
- How MFI provides insight into the PLGA microparticle characteristics that affect drug release rate and clinical efficacy
- Practical methods for utilizing MFI to simplify particle analysis workflows
Produced with support from:
Miranda van Beers, Ph.D.
Dr. Reddy’s Research and Development B.V.